First-of-its-Kind Hearing Implant System Cleared by the FDA
Pfizer manufacturers the EpiPen for Mylan and has cited manufacturing delays and problems with the supply of a component of the product from a third-party as reasons behind the shortage. Update (August 1, 2018): Supply of Mylan’s EpiPen in Canada continues to be affected by a manufacturing-related issue at a Pfizer-owned plant which produces the autoinjectors. Both the 0.3mg and 0.15mg doses will be in short supply through August, though the company told Health Canada more devices could be available by the end of the month. Update (May 10, 2018): The EpiPen shortage is now affecting patients in the US,…